Results 171 to 180 of about 5,370,035 (306)

Single-cell analysis reveals multi-faceted features of B cell development, together with age-associated B cell subpopulations. [PDF]

Commun Biol
Yang X, Tang H, Lan C, He W, Chen S, Zeng H, Liu D, Wu H, Wang W, Zhang Z.   +9 more
europepmc   +1 more source

Differently expressed genes between Follicular B cells from control (CD19-Cre) and conditional Notch2-KO (Notch2fl/fl x CD19-Cre) mice

Lothar J. Strobl
openalex   +1 more source

B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells [PDF]

, 1996
R. H. Roth, T. Nakamura, Mark J. Mamula
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

The Elusive B Cell Antigen in Multiple Sclerosis: Time to Rethink CNS B Cell Functions. [PDF]

Int J Mol Sci
Mailaender F, Vasilenko N, Tieck MP, Schembecker S, Kowarik MC.   +4 more
europepmc   +1 more source

Evaluation of T-cell and B-cell epitopes and design of multivalent vaccines against HTLV-1 diseases.

, 2003
Roshni Sundaram
openalex   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

A case of transformation of Waldenström's Macroglobulinemia to diffuse large B cell lymphoma. [PDF]

Oxf Med Case Reports
Ali MB, Kline K.
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Current treatment algorithm: diffuse large B cell lymphoma. [PDF]

Blood Cancer J
Ansell SM, Nowakowski GS.
europepmc   +1 more source